1. Home
  2. TIVC vs LCFY Comparison

TIVC vs LCFY Comparison

Compare TIVC & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • LCFY
  • Stock Information
  • Founded
  • TIVC 2016
  • LCFY 2009
  • Country
  • TIVC United States
  • LCFY Australia
  • Employees
  • TIVC N/A
  • LCFY N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • LCFY
  • Sector
  • TIVC Health Care
  • LCFY
  • Exchange
  • TIVC Nasdaq
  • LCFY Nasdaq
  • Market Cap
  • TIVC 3.7M
  • LCFY 3.7M
  • IPO Year
  • TIVC 2021
  • LCFY 2022
  • Fundamental
  • Price
  • TIVC $3.95
  • LCFY $5.91
  • Analyst Decision
  • TIVC
  • LCFY
  • Analyst Count
  • TIVC 0
  • LCFY 0
  • Target Price
  • TIVC N/A
  • LCFY N/A
  • AVG Volume (30 Days)
  • TIVC 23.7K
  • LCFY 4.9M
  • Earning Date
  • TIVC 08-13-2025
  • LCFY 07-07-2025
  • Dividend Yield
  • TIVC N/A
  • LCFY N/A
  • EPS Growth
  • TIVC N/A
  • LCFY N/A
  • EPS
  • TIVC N/A
  • LCFY N/A
  • Revenue
  • TIVC $516,000.00
  • LCFY $2,668,385.00
  • Revenue This Year
  • TIVC N/A
  • LCFY N/A
  • Revenue Next Year
  • TIVC N/A
  • LCFY N/A
  • P/E Ratio
  • TIVC N/A
  • LCFY N/A
  • Revenue Growth
  • TIVC N/A
  • LCFY N/A
  • 52 Week Low
  • TIVC $2.43
  • LCFY $2.28
  • 52 Week High
  • TIVC $16.08
  • LCFY $13.98
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 48.91
  • LCFY 59.38
  • Support Level
  • TIVC $3.75
  • LCFY $5.39
  • Resistance Level
  • TIVC $4.15
  • LCFY $13.98
  • Average True Range (ATR)
  • TIVC 0.20
  • LCFY 0.99
  • MACD
  • TIVC 0.04
  • LCFY 0.42
  • Stochastic Oscillator
  • TIVC 60.00
  • LCFY 27.81

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About LCFY Locafy Limited

Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has two operating segments: Publishing and SEO agency. Under the Publishing segment are products and services that the Company offers that are related to digital properties (i.e. mastheads) that it owns e.g. business data published on Hotfrog, advertising placed on AussieWeb, articles published on scoop.com.au. In contrast, under the SEO Agency segment are products and services that are applied to digital properties that are owned and operated by third parties. It derives a majority of its revenue in North America from SEO Agency.

Share on Social Networks: